Tradestie Institutional Equity Comparison Engine
DCTH vs TNDM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DCTH Overall Edge
DCTH Captures Institutional Edge (3โ0 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus TNDM at N/M Forward P/E and -2.4% operating margin (+13.8% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against TNDM sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
DCTH N/M vs TNDM N/M Fwd P/E
Growth & Margin Winner
DCTH
Op Margin 5.2% vs -2.4% ยท YoY +70.7% vs +13.8%
Momentum & Technical Winner
DCTH
1Y +128.6% vs +9.0% ยท 52W Pos 80% vs 39%
Options & Structure Winner
DCTH
BREAKOUT (43rd %ile IV) vs CONSOLIDATION (10th %ile IV)
DCTH
NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap
$743.8M
1M Return
+39.77%
1Y Return
+128.57%
Forward P/E
N/M
Unified AI Score
35.9 / 100
SELL
Tech 50.0
Fund 38.0
Flow 60.0
Mom 54.0
TNDM
NASDAQ
Tandem Diabetes Care, Inc.
Surgical & Medical Instruments & Apparatus
$19.11
-4.78% 1D
Market Cap
$1.2B
1M Return
+17.67%
1Y Return
+9.01%
Forward P/E
N/M
Unified AI Score
37.1 / 100
SELL
Tech 51.0
Fund 37.0
Flow 57.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DCTH +128.57%
TNDM +9.01%
Spread: +119.56 pp (DCTH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DCTH Revenue | TNDM Revenue | DCTH Op. Margin | TNDM Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $180M | N/A | -24.3% | TNDM |
| FY2019 | N/A | $360M | N/A | -4.6% | TNDM |
| FY2020 | N/A | $500M | N/A | -1.6% | TNDM |
| FY2021 | $0M | $700M | -690.0% | 3.2% | TNDM |
| FY2022 | $0M | $800M | -1245.1% | -11.6% | TNDM |
| FY2023 | $0M | $750M | -1849.0% | -31.2% | TNDM |
| FY2024 | $40M | $940M | -33.4% | -10.5% | TNDM |
| FY2025 | $90M | $1.01B | 0.8% | -18.5% | DCTH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DCTH | TNDM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $743.8M | $1.2B | Larger Scale | TNDM |
| Trailing P/E Ratio Valuation | 133.6x | 55.2x | Lower Multiple | TNDM |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +70.7% | +13.8% | Higher Growth | DCTH |
| Operating Margin (TTM) Profitability | 5.2% | -2.4% | Higher Margin | DCTH |
| Net Profit Margin Profitability | 6.0% | -4.6% | Higher Margin | DCTH |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -36.7% | Higher ROE | DCTH |
| 52-Week Range Position Momentum | 80% ($8โ$23) | 39% ($12โ$30) | Stronger Trend | DCTH |
| Beta / 30D Volatility Risk Regime | 1.63ฮฒ ยท 131% Vol | 1.15ฮฒ ยท 88% Vol | Lower Realized Risk | TNDM |
| Unified Institutional Score Composite Signal | 35.9 / 100 (SELL) | 37.1 / 100 (SELL) | Higher Composite | TNDM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DCTH vs TNDM Buy Guide
DCTH
BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
TNDM
CONSOLIDATION
68d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DCTH nor TNDM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.